Physician profile
Rania Khan
NPI 1922257997
$1,747.90
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $166 · 2021: $216 · 2022: $193 · 2023: $245 · 2024: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $730 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $729.91 |
| Food and Beverage | $288.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $774.01 | 2024 | Gelpoint V-Path |
| Abbvie INC. | $115.06 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.09 | 2019-2022 | |
| Ethicon US, LLC | $102.89 | 2023 | Vistaseal, Ethicon, Surgiflo Hemostatic Matrix |
| Avion Pharmaceuticals | $81.87 | 2020-2021 | |
| Exeltis, USA INC. | $73.49 | 2020-2022 | |
| Organon LLC | $57.39 | 2021-2023 | Nexplanon |
| Coopersurgical, INC. | $49.87 | 2020-2023 | Paragard T 380a |
| Pfizer INC. | $44.69 | 2019 | |
| Vertical Pharmaceuticals, LLC | $43.32 | 2019 | |
| Agile Therapeutics, INC. | $41.61 | 2021 | |
| Evofem Biosciences, INC. | $41.53 | 2021-2022 | |
| Hologic Sales and Service, LLC | $37.70 | 2019-2021 | |
| Myovant Sciences INC. | $29.63 | 2021-2022 | |
| Coloplast Corp | $26.41 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.58 | 2020 | |
| Astellas Pharma US INC | $22.02 | 2023 | Veozah |
| Daiichi Sankyo INC. | $15.69 | 2019 | |
| Roche Diagnostics Corporation | $15.41 | 2021 | |
| Baxter Healthcare | $14.10 | 2019 | |
| Baudax Bio INC. | $14.05 | 2020 | |
| Therapeuticsmd, INC. | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rania Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.